Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Joseph Scharpf, MD, FACS, is a Staff Member of the Cleveland Clinic’s Head and Neck Institute in the Head and Neck Surgery section. He is board-certified in Otolaryngology, Head and Neck Surgery. His specialty interests include head and neck cancer and reconstructive surgery, thyroid and parathyroid surgery, benign head and neck tumors including salivary tumors and paragangliomas, and skull base surgery. He serves as the Director of Head and Neck Endocrine Surgery at The Cleveland Clinic.
Dr. Scharpf’s education includes a Bachelor of Arts, Summa Cum Laude, from Case Western Reserve University and a Medical Doctorate from the Ohio State University College of Medicine and Public Health, where he was inducted into the Alpha Omega Alpha Honor Society. He completed a general surgery internship and an otolaryngology, head and neck surgery residency including an additional year of research at the Cleveland Clinic. He pursued further fellowship training in advanced head and neck cancer, endocrine, and reconstructive surgery at the University of Iowa in Iowa City, IA before returning to the Cleveland Clinic.
He has published numerous journal articles and multiple book chapters on head and neck cancer and reconstruction, and has delivered numerous presentations both nationally and internationally. Dr. Scharpf also serves as an educator, teaching medical students, residents, and fellows. He is a reviewer for several major scientific journals in his field and has served as a consultant for ThyCa, an organization dedicated to the well-being of those afflicted with thyroid cancer.
Dr. Scharpf is a Fellow of the American College of Surgeons, a member of the American Academy of Otolaryngology-Head and Neck Surgery, the American Thyroid Association, and a member of the American Head and Neck Society.
gland/thyroid gland tumors/chemodectomas of the head and neck, head and neck cancer, head and neck endocrine (thyroid and parathyroid) surgery, head and neck reconstructive surgery, Head And Neck Tumors, Microvascular Reconstruction, Microvascular Surgery, paranasal sinus disease, skull base surgery
American Head and Neck Society (AHNS)
American College of Surgeons (ACS)
American Thyroid Association (ATA)
American Academy of Otolaryngology
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/2/2016, Dr. Scharpf has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.